Overview

Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation

Status:
Withdrawn
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to take a population of lung transplant recipients who meet UCLA criteria for induction chemotherapy with thymoglobulin and prospectively study weather giving the first dose intraoperatively versus postoperatively makes a difference with how patients do during and after lung transplantation.
Phase:
Phase 3
Details
Lead Sponsor:
University of California, Los Angeles
Collaborator:
Genzyme, a Sanofi Company
Treatments:
Antilymphocyte Serum
Thymoglobulin